期刊文献+

伽玛刀治疗晚期胰腺癌的临床研究 被引量:12

Clinical research in advanced pancreatic carcinoma with gamma rays
下载PDF
导出
摘要 目的探讨立体定向放射治疗晚期胰腺癌的近期临床疗效.方法采用OUR-QGD型立体定向伽玛射线体部治疗系统(体部伽玛刀)治疗了31例晚期胰腺癌患者.伽玛刀治疗采用三维立体定向治疗计划系统给予患者精确定位,采用旋转聚焦原理使60℃o放射源围绕肿瘤中心作锥状非共面穿射聚焦至靶区.通常剂量为50%~65%等剂量曲线包绕靶区的95%以上;肿瘤≤5 cm的单次周边剂量3.5~4.5 Gy,肿瘤>5 cm的单次周边剂量3.0~4.0 Gy;治疗总剂量为32~48 Gy;治疗次数8~11次,大多数患者为隔日治疗.结果伽玛刀治疗过程中既有患者上腹部及腰背部疼痛明显减轻,12位患者黄疸消退.伽玛刀治疗3个月第1次复查,病变部位达到CR:10例,PR:16例;总有效率(CR+PR)83.8%.未见穿孔、大出血、持续高热等严重并发症发生.结论体部伽玛刀治疗晚期胰腺癌能使肿瘤局部得到准确的高剂量照射,周围正常组织损伤小,近期疗效理想,为临床肿瘤医师提供了一个新的治疗手段. To discuss the feasibility of treating Advanced Pancreatic Carcinoma(PC) with Stereotactic Radiation Treatment(SRT). 31 cases of Advanced PC were treated with OUR-QGD type Stereotactic Radiotherapy Gamma Rays System. Dose Curve of this group of cases is 50%~65%. Encircled dose of carcinoma which are less than or equal to 5 cm is 3.5~4.5 Gy per fraction, of carcinoma which are greater than 5 cm is 3.0~4.0 Gy per fraction. The range of total dose is 32~48 Gy. Number of treatment is 8~11. Majority of the patients are treated every other day. During the SRT period, significant pain relief has been observed in upper abdomen, waist and back of patients′ body, and jaundice of 12 cases has faded. After 3 months with SRT, CR is 10, PR is 16. Efficacious ratio(CR+PR) is 83.8%. No perforation, serious bleeding or continuous high fever has been discovered. [Conclusion] Treating Advanced PC with SRT ensures that Pancreatic carcinoma get exact high-dose radiation, with little damage to the normal tissues nearby. SRT has provided clinical radiotherapists with a safe and efficient treatment method.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2005年第5期723-725,共3页 China Journal of Modern Medicine
关键词 晚期胰腺癌 体部伽玛刀 立体定向治疗 pancreatic carcinoma gamma rays stereotactic radiotherapy
  • 相关文献

参考文献7

  • 1牛道立,盛蓁,胡慧玲,任春丽.立体定向放射治疗体部肿瘤121例疗效分析[J].中国现代医学杂志,1999,9(10):51-52. 被引量:16
  • 2喻美贞,胡从良,梁石诚.89例胰腺癌治疗疗效分析[J].中华放射肿瘤学杂志,2000,9(1):69-69. 被引量:21
  • 3BOTrGER TC, JUNGINGER T. Factors influencing morbidity and mortality after pancreatic coduodenectomy :critical analysis of 221 resections[J]. World J Srug, 1999, 23(2):164-172.
  • 4孙燕.胰腺癌,附录[A].见:孙燕主编.内科肿瘤学[M].北京:人民卫生出版社,2001.640-673,994-997.
  • 5COX JD, STETZ J, PAJAK TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)[J]. Int J Radiat Oncol Biol Phys, 1995, 31: 1341-1346.
  • 6段永建,韩晓莉,唐文春,吴大鹏,戚丽霞.立体定向适形放射治疗胰腺癌的近期疗效评价[J].中国现代医学杂志,2002,12(6):98-98. 被引量:5
  • 7JINMING YU, YONGHUA YU, YONG YIN, et al. 13 Analytical cases of pancreatic carcinoma with X-ray Stereotectonic Radiation Treatment[J]. Chin J Radiat Oncol, 2001, 10(2): 125-126.

二级参考文献12

  • 1陈妙兰 张天泽.肿瘤诊治工作常用统计指标和统计方法.中国常见肿瘤诊治规范(第九分册)[M].北京:北京医科大学中国协和医科大学联合出版社,1991.13.
  • 2James DA.Chemotherapy for pancreatic carcinoma.Cancer,1996;78:654~663
  • 3Jeffrey WC,Arvin SG,Harold JW.Systemic and adjuvant therapy for patients with pancreatic carcinoma Cancer,1996;78(suppl):688~693
  • 4Simon RB,John PN.Adjuvant Chemotherapy in pancreatic cancer Int J Pancreatol,1997;21:59~63
  • 5Watunapa P,Williamson RL.Resection of the pancreatic head with or without gastrectomy.World J Surg,1995;19:403
  • 6Bottger TC,Juniner T.Factors influencing morbidity and moprtality after pancreaticoduo denectomy critical analysis of 221 resections.World J Srug,1999;23:164
  • 7Palmer KR,Kerr M,Knowles G,et al.Chemotherapy prolongs survival in inoperatable pancreatic carcinoma.Br J Surg,1994;81:882~885
  • 8Malcolm Moore.Activity of Gemcitabine in patients with advanced pancreatic carcinoma.Cancer,1996;78:633~638
  • 9Hamilton AJ,Lulu BA,Fosmire H,et al.Preliminary clinical experience with linear accele ratorbased spinal stereotaltic radiosurgery.Neuro surgery,1995;36:311
  • 10Jess WP JM,Posnerm,Huberman.Inflanese of Multimdality therapy on the management of pancreas Carcinoma.Semin Surg Oncol,1993;9(1):27~32

共引文献35

同被引文献97

引证文献12

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部